Conductive Nanoparticle Cavitation for Targeted Cell Manipulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatment methods, especially for metastatic cancer, face challenges in localizing and treating microscopic diffuse metastatic deposits, as conventional therapies like chemotherapy and radiotherapy are not effective on all cancer cells, leading to resistance and patient mortality.
Innovation Solution
A method involving the use of pulsed optical fields to manipulate conductive nanoparticles near cells, inducing cavitations for cell damage or fusion, allowing for targeted cell modification, including apoptosis, necrosis, or hybridoma formation, using specifically attached nanoparticles to enhance treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional chemotherapy or radiotherapy is used to treat metastatic cancer, then systemic treatment coverage is achieved, but treatment resistance develops and not all cancer cells are effectively eliminated
Solution Approach 1:
The patent applies local quality by using nanoparticles conjugated with antibodies that specifically target and accumulate at the site of metastatic cancer cells. The optical field is then localized to irradiate only the nanoparticles at the tumor site, creating highly localized thermal and mechanical effects that destroy cancer cells while spares surrounding healthy tissue. This resolves the contradiction by achieving effective treatment (improving reliability) while avoiding the systemic resistance problem through localized action.
Solution Approach 2:
The patent uses nanoparticles as intermediaries between the optical field and cancer cells. The nanoparticles are conjugated with antibodies that serve as mediators to specifically bind to cancer cell surfaces. This intermediary system enables selective delivery of optical energy to cancer cells, improving treatment effectiveness while avoiding the harmful effect of treating resistant cells with conventional systemic therapies.
2Manufacturing precision
If laser light is used for non-invasive detection and destruction of malignant cells, then treatment specificity is improved, but conventional methods cannot effectively treat microscopic diffuse metastatic deposits
Solution Approach 1:
The patent employs nanoparticles conjugated with antibodies as intermediaries that can penetrate and accumulate in microscopic metastatic deposits. These nanoparticles serve as both the delivery vehicle for optical energy and the target for antibody-mediated recognition, enabling detection and treatment of microscopic deposits that are otherwise undetectable to conventional methods.
Solution Approach 2:
The patent utilizes parameter changes by adjusting the optical field parameters (wavelength, intensity, pulse duration) to match the plasmon resonance frequency of the nanoparticles. This resonance condition enhances the local optical field strength dramatically, enabling effective treatment of microscopic deposits with low background signal, thus resolving the detectability problem while maintaining high treatment localization precision.
3Reliability
If photosensitizers are administered for photo-dynamic therapy, then cancer cell destruction is achieved through free radical production, but surrounding healthy tissue may be damaged
Solution Approach 1:
The patent extracts the harmful thermal and mechanical effects from the optical field by using nanoparticles as intermediaries. The nanoparticles absorb the optical energy and convert it to localized thermal and mechanical effects through plasmon resonance, concentrating the destructive action solely at the nanoparticle-cancer cell interface. This extraction prevents the harmful effects from propagating to surrounding healthy tissue while maintaining effective cancer cell destruction.
Solution Approach 2:
The patent applies local quality by using nanoparticles that specifically accumulate at cancer cell sites through antibody conjugation. The optical field is then localized to irradiate only these nanoparticles, creating highly localized thermal and mechanical effects that destroy cancer cells while spares surrounding healthy tissue. This resolves the contradiction by achieving effective treatment (improving reliability) while avoiding the harmful effect of damaging healthy tissue.
4Reliability
If conductive nanoparticles are used to locally increase optical field power for cell ionization, then cell destruction is achieved, but the complexity of the treatment system increases
Solution Approach 1:
The patent uses nanoparticles as simple intermediary particles that can be passively delivered to cancer cells through their natural accumulation in tumor tissue or through simple antibody conjugation. This simple intermediary approach avoids the need for complex delivery systems, gene therapy vectors, or multiple drug regimens, thereby achieving effective cell destruction while minimizing treatment system complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise manipulation of cells, including targeted cell damage and fusion, potentially improving cancer treatment outcomes by enhancing the effectiveness of therapies and monoclonal antibody production.
Implementation Method 1
directing a pulsed optical field to at least one conductive nanoparticle present in the vicinity of the cell, so as to generate cavitations at or near the conductive nanoparticle at sufficient amount to effect at least one cell modification
Implementation Method 2
Laser technology has found many applications in medicine and biology including destruction of cells or tissues... through activation of some photochemical reactions using light-activated molecules
Data Source
AI summary
A method of manipulating a living cell is disclosed. The method comprises, directing a pulsed optical field to at least one conductive nanoparticle present in the vicinity of the cell, so as to generate cavitations at or near the conductive nanoparticle at sufficient amount to effect at least one cell modification selected from the group consisting of cell-damage and cell-fusion.